Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Needham reiterated a Hold rating on Globus Medical (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an impressive revenue growth of 102% over the last twelve ...

GMED is a #3 (Hold) on the Zacks Rank ... For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year.

Implementations remain one of the weakest aspects of the EHR experience, with customer satisfaction dropping significantly since 2022, KLAS Research reported. About 40% of healthcare leaders ...

One promising solution lies in the integration of Electronic Health Records (EHR) systems. For rural hospitals that often operate with a patchwork of platforms like Cerner, Epic, Meditech ...

But Epic's wins keep piling up, with Newark, Delaware-based ChristianaCare and University of Alabama Health system both committing to the EHR vendor in 2024. The cost of Epic is high but health ...

Becker's caught up with Robert Hartmann, the new vice president of EHR transformation at the three-hospital system, about his plans and hopes for the Epic switch. The conversation has been lightly ...

We list the best typing tutor software, to make it simple and easy to learn how to type faster and more efficiently. Being able to type quickly and accurately is an essential skill that takes ...

Globus Medical GMED continues to gain from surging demand ... It is currently the only freehand navigation system on the market to offer the versatility of three distinct imaging workflows.